VSTM2L and gastric cancer: A previous study has shown that VSTM2L was downregulated in H. pylori-positive gastric cancer patients compared to patients who were H. pylori-negative in TCGA and was expressed at a lower level in gastric cancer tissue compared to adjacent normal tissue (Hu et al., 2018), which was supported by our work.